Finally, we identified five key EMT pathways dysregulated in CF cells and several proteins among the F508del-CFTR–specific YAP1 interactors, which emerge as major hubs possibly mediating the crosstalk among these pathways and appearing as potential therapeutic targets for both CF and cancer. The gene discussed is YAP1; the disease is cystic fibrosis.